10 Jul, 2024 Challenges and opportunities for bio innovation: Views from the ON Helix 2024 conference By Adam Coughlin Luca Cericola Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...
08 Jul, 2024 Labour's planning reforms for the life sciences sector By Tim Allen Hugo Kent-Egan “To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...
04 Jul, 2024 The EU AI Act as product safety legislation – lessons from the world of medical devices By Alex Denoon If an AI system is classified as “high-risk”, the AI Act imposes significant requirements on the provider in order for it to place the...
25 Jun, 2024 Biotech Review of the Year: Six months on By Bristows LLP It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...
17 Jun, 2024 Licence Agreements for Cell and Gene Therapies By Claire Smith Ellen Lambrix Louisa Jacobs This article was first published in The Licensing Journal (Volume 44, Number 4). You can read and/or download it, in full, below: Cell...
13 Jun, 2024 Takeaways from the EU Pharma Law Forum 2024 By Jamie Hatzel Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...
24 May, 2024 Clinical combinations: ever increasingly, two study products are better than one By Claire Smith Adam Coughlin Forgive the poetic licence but it feels like almost every week a new agreement for a clinical combination therapy lands on our desks....
24 May, 2024 Global Talent 24: a spotlight on the Life Sciences sector By Gareth Wadley Manon Rattle We are delighted to have collaborated with Mark Abbs (Global Mobility Partner at Blick Rothenberg) on a global talent report for the Life...
01 May, 2024 Highlights from the ABPI Annual Conference 2024 By Hugo Kent-Egan We enjoyed an interesting day hearing about the future of the UK life sciences industry at the ABPI Annual Conference 2024. The...
01 Mar, 2024 MHRA grants first medicine approval via the new International Recognition Procedure By Jamie Hatzel For the very first time, the MHRA has a granted a UK marketing authorisation (UKMA) for a medicine through its new International...
21 Feb, 2024 Will it be possible to lawfully test an AI Medical Device? By Alex Denoon A brief analysis of the interaction between the proposed AI Act and the MDR The AI Act continues to contain a concerning flaw as regards...
29 Jan, 2024 Implementation deadlines for the EU In Vitro Diagnostic Medical Device Regulation further postponed By Alex Denoon Melissa Dix Extending the transitional periods for implementation A considerable number of in vitro diagnostic medical devices (IVDs) currently on...